September 15, 2020
Vascugenix is a medical device company focused on developing innovative products to improve interventional cardiovascular procedures, is preparing to launch its first developed device, the Speed-Torque, in the U.S. market.
The Vascugenix team partnered with Gilero, a medical device design, development, and manufacturing company, to take this novel product idea from concept to commercialization.
“Vascugenix has worked closely with Gilero over the past nine months to develop and commercialize the Speed-Torque. Bringing a new device to the market during the COVID pandemic has been challenging, but Gilero and Vascugenix have worked closely together to make it happen,” says Martial Trigeaud, Chief Operating Officer for Vascugenix.
“Thanks to the dedication of Gilero, as well their Shenzhen-based injection molding partner Medacys, we were able to fully develop this device and bring it to market in a relatively short period of time,” adds Trigeaud. “The team at Vascugenix is excited to bring this product to market. The Speed-Torque will ultimately save physicians time, hospitals money, and improve patient safety.”